Literature DB >> 500939

Comparative haemodynamic effects of dopamine and dobutamine in septic shock.

B Regnier, D Safran, J Carlet, B Teisseire.   

Abstract

Septic shock associated with depressed myocardial function generally requires the use of catecholamine. Currently dopamine is often selected. Dobutamine is a newly developed catecholamine which has been shown to be of value in severe cardiomyopathic disease. The aim of this work was to determine the most appropriate drug by comparing haemodynamic responses to dopamine and dobutamine in 19 studies carried out in 11 patients with septic shock and heart failure. Cardiac index increased siliarly with dopamine and dobutamine (33%), as did stroke volume (respectively 26.4 and 25%). Arterial pressure increased by 17% with dopamine whereas it did not significantly change with dobutamine due to reduction in vascular resistance of 19%. Dobutamine decreased filling pressure, either right (14%) of left (28%) whilst they slightly but unsignificantly increased with dopamine. Pulmonary shunting increased more with dopamine (47%) than with dobutamine (16%), but PaO2 remained constant with both. Since septic shock is characterized by lowered arterial pressure and vasodilatation it is concluded that effects of dopamine on capacitance and resistance vessels make this drug more suitable. In addition it selectively increases renal blood flow. Nevertheless dobutamine could be appropriate, in case of very high filling pressures, severe peripheral vasoconstriction, marked pulmonary shunting and in some cases where dopamine becomes ineffective.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 500939     DOI: 10.1007/bf01683192

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  29 in total

1.  Hemodynamic effects of dopamine in critically ill septic patients.

Authors:  R F Wilson; W J Sibbald; J L Jaanimagi
Journal:  J Surg Res       Date:  1976-03       Impact factor: 2.192

2.  Haemodynamic effects of dopamine in septic shock.

Authors:  B Regnier; M Rapin; G Gory; F Lemaire; B Teisseire; A Harari
Journal:  Intensive Care Med       Date:  1977-08       Impact factor: 17.440

3.  Evaluation of the pharmacologic basis for the therapy of circulatory shock.

Authors:  N C Moran
Journal:  Am J Cardiol       Date:  1970-12       Impact factor: 2.778

4.  The treatment of shock with beta adrenergic blockade.

Authors:  J L Berk; J F Hagen; G Maly; R Koo
Journal:  Arch Surg       Date:  1972-01

5.  Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in conscious dogs.

Authors:  S F Vatner; R J McRitchie; E Braunwald
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

6.  Effectiveness of dopamine in patients with cardiogenic shock.

Authors:  J Holzer; J S Karliner; R A O'Rourke; W Pitt; J Ross
Journal:  Am J Cardiol       Date:  1973-07       Impact factor: 2.778

7.  Nitrate effects on cardiac output and left ventricular outflow resistance in chronic congestive heart failure.

Authors:  J A Franciosa; R C Blank; J N Cohn
Journal:  Am J Med       Date:  1978-02       Impact factor: 4.965

8.  Cardiovascular function in shock. Responses to volume loading and isoproterenol infusion.

Authors:  J S Carey; R S Brown; P A Mohr; D O Monson; S T Yao; W C Shoemaker
Journal:  Circulation       Date:  1967-02       Impact factor: 29.690

9.  Hemodynamic effect of dobutamine in patients with severe heart failure.

Authors:  N Akhtar; E Mikulic; J N Cohn; M H Chaudhry
Journal:  Am J Cardiol       Date:  1975-08       Impact factor: 2.778

10.  Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure.

Authors:  C V Leier; P T Heban; P Huss; C A Bush; R P Lewis
Journal:  Circulation       Date:  1978-09       Impact factor: 29.690

View more
  9 in total

1.  Comparison of the effects of dopamine and dobutamine during continuous positive-pressure ventilation.

Authors:  M Brandl; T Pasch; H D Kamp; J Grimm
Journal:  Intensive Care Med       Date:  1983       Impact factor: 17.440

2.  Pharmacological treatment of pulmonary oedema.

Authors:  J Carlet; M Francoual; F Lhoste; B Regnier; F Lemaire
Journal:  Intensive Care Med       Date:  1980       Impact factor: 17.440

Review 3.  The influence of catecholamines on right ventricular function in septic shock.

Authors:  W O Schreuder; A J Schneider; A B Groeneveld; L G Thijs
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

4.  Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.

Authors:  Laura Evans; Andrew Rhodes; Waleed Alhazzani; Massimo Antonelli; Craig M Coopersmith; Craig French; Flávia R Machado; Lauralyn Mcintyre; Marlies Ostermann; Hallie C Prescott; Christa Schorr; Steven Simpson; W Joost Wiersinga; Fayez Alshamsi; Derek C Angus; Yaseen Arabi; Luciano Azevedo; Richard Beale; Gregory Beilman; Emilie Belley-Cote; Lisa Burry; Maurizio Cecconi; John Centofanti; Angel Coz Yataco; Jan De Waele; R Phillip Dellinger; Kent Doi; Bin Du; Elisa Estenssoro; Ricard Ferrer; Charles Gomersall; Carol Hodgson; Morten Hylander Møller; Theodore Iwashyna; Shevin Jacob; Ruth Kleinpell; Michael Klompas; Younsuck Koh; Anand Kumar; Arthur Kwizera; Suzana Lobo; Henry Masur; Steven McGloughlin; Sangeeta Mehta; Yatin Mehta; Mervyn Mer; Mark Nunnally; Simon Oczkowski; Tiffany Osborn; Elizabeth Papathanassoglou; Anders Perner; Michael Puskarich; Jason Roberts; William Schweickert; Maureen Seckel; Jonathan Sevransky; Charles L Sprung; Tobias Welte; Janice Zimmerman; Mitchell Levy
Journal:  Intensive Care Med       Date:  2021-10-02       Impact factor: 17.440

5.  The influence of PEEP ventilation on organ blood flow and peripheral oxygen delivery.

Authors:  J Beyer; P Beckenlechner; K Messmer
Journal:  Intensive Care Med       Date:  1982-03       Impact factor: 17.440

6.  Dobutamine in elderly septic shock patients refractory to dopamine.

Authors:  B Tell; T C Majerus; L Flancbaum
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

7.  Effects of norepinephrine on right ventricular function in septic shock patients.

Authors:  C Martin; G Perrin; P Saux; L Papazian; F Gouin
Journal:  Intensive Care Med       Date:  1994-07       Impact factor: 17.440

Review 8.  Inodilators in septic shock: should these be used?

Authors:  Gustavo A Ospina-Tascón; Luis E Calderón-Tapia
Journal:  Ann Transl Med       Date:  2020-06

Review 9.  The spectrum of cardiovascular effects of dobutamine - from healthy subjects to septic shock patients.

Authors:  Arnaldo Dubin; Bernardo Lattanzio; Luis Gatti
Journal:  Rev Bras Ter Intensiva       Date:  2017 Oct-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.